Xerox Raises $450 Million for New Joint Venture to Strengthen Balance Sheet and Support Long-Term Strategy
NORWALK, Conn.–(BUSINESS WIRE)–Xerox Holdings Corporation (NASDAQ: XRX) (“Xerox” or the “Company”) today announced the formation and capitalization... Read more.
ManageEngine Introduces Causal Intelligence and Autonomous AI to IT Operations for Faster Incident Response
New Site24x7 Capabilities Combine Domain-Aware Correlations, autonomous AI, And Workflow Orchestration To Drive Self-Healing IT Operations Delivers faster root-cause... Read more.
UNC Health Selects Mevion to Advance Next-Generation Proton Therapy Deployment
Leading Academic Health System Expands Access with Compact, Single-Room Proton Technology LITTLETON, Mass.–(BUSINESS WIRE)–#MevionFIT–Mevion Medical... Read more.
True Fit Launches Agentic AI Shopping Experience Powered by 20 Years of Fit Data
New Shopping Agent Solves ‘Will This Fit?’ Indecision With Purchase Data From Hundreds of Millions of Shoppers BOSTON–(BUSINESS WIRE)–#AI–True... Read more.
IHS Towers Agrees to Sell Latin America Tower Operations to Macquarie Asset Management
LONDON & SÃO PAULO–(BUSINESS WIRE)–IHS Mauritius BR Limited, part of IHS Holding Limited (NYSE: IHS) (“IHS Towers” or the “Company”), one... Read more.
Conduent Study Reveals Human Connection in HR Strongly Influences Employee Perceptions
Data shows HR teams balancing employee demand for human interaction with growing technology adoption FLORHAM PARK, N.J.–(BUSINESS WIRE)–New research... Read more.
Vektor Medical Announces EP Europace Publication: vMap-Guided Ablation Associated with Improved One-Year Arrhythmia-Free Survival in Unstable Ventricular Tachycardia Patients
80% One-Year Arrhythmia-Free Survival Achieved Without Increased Procedure Time, Fluoroscopy, or Complications SAN DIEGO–(BUSINESS WIRE)–#Medtech—Vektor... Read more.
Central Garden & Pet Announces Increase in Stock Repurchase Authorization
WALNUT CREEK, Calif.–(BUSINESS WIRE)–$CENT #CentralToHome–Central Garden & Pet Company (NASDAQ: CENT) (NASDAQ: CENTA), a leading consumer goods... Read more.
Omeros Announces Successful Primate Study in OncotoX-AML™ Drug Program
— OncotoX-AML Effectively Ablated Myeloid Progenitor Cells that Give Rise to AML in Cancer Patients — SEATTLE–(BUSINESS WIRE)–Omeros Corporation... Read more.
Investors Title Company Announces Fourth Quarter and Fiscal Year 2025 Results
CHAPEL HILL, N.C.–(BUSINESS WIRE)–Investors Title Company (Nasdaq: ITIC) today announced results for the fourth quarter ended December 31, 2025. The... Read more.